Impact of icodextrin on clinical outcomes in peritoneal dialysis: A systematic review of randomized controlled trials

Nephrology Dialysis Transplantation

Volumn 28, Issue 7, 2013, Pages 1899-1907

  Cho, Yeoungjee ^a   Johnson, David W ^a   Badve, Sunil ^a   Craig, Jonathan C ^b   Strippoli, Giovanni F K ^b,c,d,e   Wiggins, Kathryn J ^f  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^d Diaverum Medical Scientific Office   (Sweden)

^e UNIVERSITY OF BARI   (Italy)

^f ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Icodextrin; Outcomes; Peritoneal dialysis; Ultrafiltration

Indexed keywords

GLUCOSE; ICODEXTRIN;

CREATININE CLEARANCE; DRUG EFFICACY; DRUG USE; HOSPITALIZATION; HUMAN; HYPERVOLEMIA; PERITONEAL DIALYSIS; PERITONITIS; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK BENEFIT ANALYSIS; SOLUTE; SURVIVAL; SYSTEMATIC REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME; ULTRAFILTRATION; UNSPECIFIED SIDE EFFECT; URINE VOLUME;

ICODEXTRIN; OUTCOMES; PERITONEAL DIALYSIS; ULTRAFILTRATION;

DIALYSIS SOLUTIONS; GLUCANS; GLUCOSE; HUMANS; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REVIEW LITERATURE AS TOPIC; SURVIVAL RATE;

EID: 84881048415     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft050     Document Type: Review

References (26)

1. Johnson DW, Agar J, Collins J et al. Recommendations for the use of icodextrin in peritoneal dialysis patients. Nephrology (Carlton) 2003; 8: 1-7
2. Wiggins KJ, Rumpsfeld M, Blizzard S et al. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure. Nephrology (Carlton) 2005; 10: 33-36
3. Konings CJ, Kooman JP, Schonck M et al. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study. Kidney Int 2003; 63: 1556-1563
4. Mujais S, Nolph K, Gokal R et al. Evaluation and management of ultrafiltration problems in peritoneal dialysis. Perit Dial Int 2000; 20(Suppl 4): S5-S21
5. van Biesen W, Heimburger O, Krediet R et al. Evaluation of peritoneal membrane characteristics: clinical advice for prescription management by the ERBP working group. Nephrol Dial Transplant 2010; 25: 2052-2062
6. Johnson DW, Arndt M, O'Shea A et al. Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload. BMC Nephrol 2001; 2: 2
7. Lefebvre CM, Glanville EJ. Chapter 6: Searching for studies. Cochrane Handbook for Systematic Reviews of Interventions, 2008. Version 5.0.0. www.cochrane-handbook.org
8. Higgins JP, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, 2009. www.cochrane-handbook.org
9. Higgins JP, Thompson SG, Deeks JJ et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560
10. Bredie SJ, Bosch FH, Demacker PN et al. Effects of peritoneal dialysis with an overnight icodextrin dwell on parameters of glucose and lipid metabolism. Perit Dial Int 2001; 21: 275-281
11. Davies SJ, Woodrow G, Donovan K et al. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a doubleblind randomized controlled trial. J Am Soc Nephrol 2003; 14: 2338-2344
12. Finkelstein F, Healy H, Abu-Alfa A et al. Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration. J Am Soc Nephrol 2005; 16: 546-554
13. Lin A, Qian J, Li X et al. Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid. Clin J Am Soc Nephrol 2009; 4: 1799-1804
14. Mistry CD, Gokal R, Peers E. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter investigation of icodextrin in ambulatory peritoneal dialysis. Kidney Int 1994; 46: 496-503
15. Paniagua R, Ventura MD, Avila-Diaz M et al. Icodextrin improves metabolic and fluid management in high and highaverage transport diabetic patients. Perit Dial Int 2009; 29: 422-432
16. Plum J, Gentile S, Verger C et al. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis. Am J Kidney Dis 2002; 39: 862-871
17. Posthuma N, ter Wee PM, Donker AJ et al. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group. Perit Dial Int 2000; 20(Suppl 2): S106-S113
18. Posthuma N, Verbrugh HA, Donker AJ et al. Peritoneal kinetics and mesothelial markers in CCPD using icodextrin for daytime dwell for two years. Perit Dial Int 2000; 20: 174-180
19. Takatori Y, Akagi S, Sugiyama H et al. Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial. Clin J Am Soc Nephrol 2011; 6: 1337-1344
20. Wolfson M, Piraino B, Hamburger RJ et al. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis. Am J Kidney Dis 2002; 40: 1055-1065
21. Qi H, Xu C, Yan H et al. Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis: a metaanalysis of randomized controlled trials. Perit Dial Int 2011; 31: 179-188
22. Posthuma N, ter Wee PM, Verbrugh HA et al. Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-h dialysate creatinine clearance. Nephrol Dial Transplant 1997; 12: 550-553
23. Bargman JM. Slouching towards Bethlehem: the beast of biocompatibility. Nephrol Dial Transplant 2010; 25: 2050-2051
24. Davies SJ. Preserving residual renal function in peritoneal dialysis: volume or biocompatibility? Nephrol Dial Transplant 2009; 24: 2620-2622
25. Martis L, Patel M, Giertych J et al. Aseptic peritonitis due to peptidoglycan contamination of pharmacopoeia standard dialysis solution. Lancet 2005; 365: 588-594
26. Wiggins KJ, Craig JC, Johnson DW et al. Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database Syst Rev 2009; Issue 1. Art. No.: CD007554. doi: 10.1002/14651858.CD007554.